There’s a single word that captures the spirit of business since the start of the pandemic: “direct.” Brands are adopting direct-to-consumer models wherever possible to trim time and costs from the distribution chain. And it’s not that different in the data world. “Direct” is the catchword of the day.
Imagine if someone were to give you hours more time in your day. Most people would gladly take it. In essence, that’s what eSource technology offers investigator sites — 30 percent more time to spend on patient care.
As Sponsors incorporate eSource technologies and decentralized data collection into their trials, barriers to patient participation and adherence are beginning to fall away.
When electronic data capture (EDC) systems came onto the clinical trial scene, no one expected them to…
New Positions Created to Manage Dramatic Growth HORSHAM, Pa.; May 4, 2021 – Clinical Ink, a global clinical trial technology company, today announced the hiring …
Clinical Ink Hires CCO Chris Crucitti, COO Brian Donahue, VP Bill Barrasso Read More…
In late September, the EMA released an important qualification opinion in favor of using eSource direct data capture (DDC) in clinical trials. The EMA’s opinion …
EMA Greenlights eSource DDC and References Clinical ink Read More…
eSource and IRT Integration Simplifies the Site Experience SAN FRANCISCO, CA & PHILADELPHIA, PA – May 18, 2017 Endpoint Clinical, the leading global interactive response technology …
Clinical ink and endpoint Announce ‘Industry-First’ Alliance Read More…
Sales and Solutions
Direct 1.336.714.7402
Support
Toll-Free 1.800.301.5033
Direct 1.336.714.7402
Insert HTML text here.
